Literature DB >> 23100343

Neonatal herpes encephalitis caused by a virologically confirmed acyclovir-resistant herpes simplex virus 1 strain.

Satsuki Kakiuchi1, Shigeaki Nonoyama, Hajime Wakamatsu, Kazuhiro Kogawa, Lixin Wang, Hitomi Kinoshita-Yamaguchi, Mutsuyo Takayama-Ito, Chang-Kweng Lim, Naoki Inoue, Masashi Mizuguchi, Takashi Igarashi, Masayuki Saijo.   

Abstract

A neonate with herpes simplex virus 1 encephalitis was treated with intravenous acyclovir. During the course of therapy, the infection became intractable to the treatment and a mutation in the viral thymidine kinase gene (nucleotide G375T, amino acid Q125H) developed. This mutation was demonstrated in vitro to confer acyclovir resistance.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23100343      PMCID： PMC3536242          DOI： 10.1128/JCM.02247-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  20 in total

1.  Nucleoside binding site of herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography.

Authors:  J Vogt; R Perozzo; A Pautsch; A Prota; P Schelling; B Pilger; G Folkers; L Scapozza; G E Schulz
Journal:  Proteins       Date:  2000-12-01

2.  Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum.

Authors:  M J Levin; A Weinberg; J J Leary; R T Sarisky
Journal:  Pediatr Infect Dis J       Date:  2001-11       Impact factor: 2.129

Review 3.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

4.  Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.

Authors:  Tomoyuki Shiota; Wang Lixin; Mutsuyo Takayama-Ito; Itoe Iizuka; Momoko Ogata; Masanori Tsuji; Hidekazu Nishimura; Shuichi Taniguchi; Shigeru Morikawa; Ichiro Kurane; Masashi Mizuguchi; Masayuki Saijo
Journal:  Antiviral Res       Date:  2011-06-02       Impact factor: 5.970

5.  Natural history of neonatal herpes simplex virus infections in the acyclovir era.

Authors:  D W Kimberlin; C Y Lin; R F Jacobs; D A Powell; L M Frenkel; W C Gruber; M Rathore; J S Bradley; P S Diaz; M Kumar; A M Arvin; K Gutierrez; M Shelton; L B Weiner; J W Sleasman; T M de Sierra; S J Soong; J Kiell; F D Lakeman; R J Whitley
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

6.  Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.

Authors:  D W Kimberlin; C Y Lin; R F Jacobs; D A Powell; L Corey; W C Gruber; M Rathore; J S Bradley; P S Diaz; M Kumar; A M Arvin; K Gutierrez; M Shelton; L B Weiner; J W Sleasman; T M de Sierra; S Weller; S J Soong; J Kiell; F D Lakeman; R J Whitley
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

7.  Detection and direct typing of herpes simplex virus by polymerase chain reaction.

Authors:  H Kimura; M Shibata; K Kuzushima; K Nishikawa; Y Nishiyama; T Morishima
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

8.  Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.

Authors:  Y Chen; C Scieux; V Garrait; G Socié; V Rocha; J M Molina; D Thouvenot; F Morfin; L Hocqueloux; L Garderet; H Espérou; F Sélimi; A Devergie; G Leleu; M Aymard; F Morinet; E Gluckman; P Ribaud
Journal:  Clin Infect Dis       Date:  2000-10-10       Impact factor: 9.079

9.  Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate.

Authors:  R J Oram; D Marcellino; D Strauss; E Gustafson; C L Talarico; A K Root; P L Sharma; K Thompson; J D Fingeroth; C Crumpacker; B C Herold
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

10.  Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance.

Authors:  A J Nahmias; R J Whitley; A N Visintine; Y Takei; C A Alford
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226
View more
  8 in total

Review 1.  Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Clin Microbiol Rev       Date:  2020-02-12       Impact factor: 26.132

2.  Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.

Authors:  Debra C Quenelle; Alexander Birkmann; Thomas Goldner; Tamara Pfaff; Holger Zimmermann; Susanne Bonsmann; Deborah J Collins; Terri L Rice; Mark N Prichard
Journal:  Antiviral Res       Date:  2017-11-04       Impact factor: 5.970

Review 3.  Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.

Authors:  Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

4.  Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients.

Authors:  Johanna G Mitterreiter; Maarten J Titulaer; Gijsbert P van Nierop; Jeroen J A van Kampen; Georgina I Aron; Albert D M E Osterhaus; Georges M G M Verjans; Werner J D Ouwendijk
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

5.  Enteroviral and herpes simplex virus central nervous system infections in infants < 90 days old: a Paediatric Investigators' Collaborative Network on Infections in Canada (PICNIC) study.

Authors:  Dara Petel; Michelle Barton; Christian Renaud; Lynda Ouchenir; Jason Brophy; Jennifer Bowes; Sarah Khan; Ari Bitnun; Jane McDonald; Andrée-Anne Boisvert; Joseph Ting; Ashley Roberts; Joan L Robinson
Journal:  BMC Pediatr       Date:  2020-05-26       Impact factor: 2.125

6.  Influence of seasonal and geographic variation on the anti-HSV-1 properties and chlorogenic acids content of Helichrysum aureonitens Sch. Bip.

Authors:  Wilson Bamise Adeosun; Garland K More; Paul Steenkamp; Gerhard Prinsloo
Journal:  Front Mol Biosci       Date:  2022-08-25

Review 7.  New strategies against drug resistance to herpes simplex virus.

Authors:  Yu-Chen Jiang; Hui Feng; Yu-Chun Lin; Xiu-Rong Guo
Journal:  Int J Oral Sci       Date:  2016-03-30       Impact factor: 6.344

Review 8.  Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease.

Authors:  Paula A Suazo; Eduardo I Tognarelli; Alexis M Kalergis; Pablo A González
Journal:  Med Microbiol Immunol       Date:  2014-09-11       Impact factor: 3.402
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.